Trinity Biotech PLC (TRIB) stock
Close on Nov 17, 2026Market cap $112.45MP/E –Yield –
Earnings
Trinity Biotech's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Trinity Biotech's earnings releases, newest first
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Trinity Biotech's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| annualised run-rate revenues | Q2 FY2025 | $75.00M | – | New | Aug 20, 2024 |
| annualized run-rate EBITDASOnon-GAAP | Q2 FY2025 | $20.00M | – | New | Aug 20, 2024 |
Guidance history
Every forecast Trinity Biotech put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 20, 2024 | annualized run-rate EBITDASO | Q2 FY2025 | $20.00M | New |
| Aug 20, 2024 | annualised run-rate revenues | Q2 FY2025 | $75.00M | New |
| Feb 1, 2024 | revenue | Q4 FY2023 | $13.00M – $14.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Trinity Biotech filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
See a number that looks wrong?